Loading...
Portfolio Diversification
Range
Most Diversified
25 instruments
January 9, 2026
Least Diversified
0 instruments
October 20, 2025
Average
18.8 instruments
Most Consistent Holdings
Top 5
BDX99.26%
DXCM99.26%
MRK99.2%
NVO99.2%
TNDM99.14%
Position Sizing
Analysis
Market Exposure
Analysis
Top Sectors
Top 5
Top Countries
Top 5
Holdings over time
(Since January 1, 2022)
| Instrument | Avg. Exposure | Current Exposure | Time Holding | Last Closed |
|---|---|---|---|---|
 Eli Lilly (LLY) | 10.9% | 5.61% | 98.77% | - |
| Merck (MRK) | 8.53% | 5.28% | 99.2% | - |
| Novo-Nordisk (NVO) | 8.13% | 3.12% | 99.2% | - |
 Abbott (ABT.US) | 5.81% | 2.97% | 98.96% | - |
 AstraZeneca (AZN.L) | 5.63% | 0% | 87.62% | 1/7/2026 |
| DexCom (DXCM) | 5.41% | 5.56% | 99.26% | - |
 Medtronic (MDT.US) | 4.74% | 3.38% | 99.08% | - |
 Insulet (PODD) | 4.21% | 2.25% | 99.08% | - |
 Johnson & Johnson (JNJ) | 3.96% | 4.98% | 73.65% | - |
| BD (BDX) | 3.51% | 2.3% | 99.26% | - |
 Roche (ROP.ZU) | 3.41% | 0% | 87.62% | 1/7/2026 |
 Sanofi (SAN.PA) | 3.4% | 0% | 87.5% | 1/7/2026 |
 Bristol-Myers Squibb (BMY) | 2.98% | 4.09% | 67.03% | - |
 Neurocrine Biosciences (NBIX) | 2.82% | 5.49% | 55.76% | - |
| Tandem Diabetes (TNDM) | 2.79% | 2.27% | 99.14% | - |
 Ascendis Pharma (ASND) | 2.79% | 4.67% | 55.94% | - |
 Alkermes (ALKS) | 2.56% | 6.54% | 55.51% | - |
 Halozyme (HALO) | 2.46% | 3.55% | 54.04% | - |
 MannKind (MNKD) | 2.25% | 2.33% | 69.55% | - |
 Bayer (BAYN.DE) | 2.18% | 0% | 43.08% | 1/3/2024 |
 Pfizer (PFE) | 1.64% | 4.7% | 33.27% | - |
 Rhythm Pharmaceuticals (RYTM) | 1.61% | 4.06% | 34.07% | - |
 Almirall (ALM.MC) | 0.97% | 0% | 43.08% | 1/3/2024 |
 GlaxoSmithKline (GSK) | 0.93% | 0% | 22.55% | 1/8/2025 |
 Sandoz (SDZNY) | 0.56% | 0% | 12.81% | 8/1/2024 |
 Viking Therapeutics (VKTX) | 0.54% | 5.04% | 11.4% | - |
 Amgen (AMGN) | 0.52% | 4.37% | 11.64% | - |
 West Pharma (WST) | 0.5% | 5.13% | 11.4% | - |
 Vertex (VRTX) | 0.5% | 4.2% | 11.46% | - |
 AstraZeneca (AZN) | 0.42% | 3.01% | 11.58% | - |
 GSK (GSK.L) | 0.42% | 0% | 10.85% | 1/3/2024 |
 Hansoh Pharmaceutical Group (3692.HK) | 0.34% | 2.59% | 11.4% | - |
 Lexicon Pharmaceuticals (LXRX) | 0.24% | 0% | 10.91% | 1/3/2024 |
 Beta Bionics Inc (BBNX) | 0.18% | 1.81% | 11.52% | - |
Exposure over time
Exposure by Sector
Exposure by Country
Portfolio Time Machine
Portfolio date
01
01
2026
| Instrument | Invested | Value |
|---|---|---|
| Eli Lilly (LLY) | 4.38% | 10.2% |
| Johnson & Johnson (JNJ) | 5.69% | 6.79% |
| Merck (MRK) | 6.25% | 6.78% |
| Ascendis Pharma (ASND) | 3.82% | 5.98% |
| AstraZeneca (AZN.L) | 4.54% | 5.71% |
| Insulet (PODD) | 4.37% | 5.34% |
| DexCom (DXCM) | 8.7% | 5.3% |
| Neurocrine Biosciences (NBIX) | 5.34% | 5.27% |
| Medtronic (MDT.US) | 5.6% | 5.03% |
| Halozyme (HALO) | 4.23% | 4.78% |
| Roche (ROP.ZU) | 5% | 4.53% |
| Abbott (ABT.US) | 4.59% | 4.49% |
| Pfizer (PFE) | 5.13% | 4.42% |
| Bristol-Myers Squibb (BMY) | 5.1% | 4.01% |
| Alkermes (ALKS) | 4.26% | 3.77% |
| BD (BDX) | 5.12% | 3.61% |
| MannKind (MNKD) | 4.12% | 3.44% |
| Sanofi (SAN.PA) | 3.96% | 3.01% |
| Tandem Diabetes (TNDM) | 3.54% | 2.66% |
| Novo-Nordisk (NVO) | 3.88% | 2.63% |
Cash & Instruments Over Time
Unlock Premium Features
Get access to this feature and many more with BullAware Pro.